Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial

Previous data established that plitidepsin, a cyclic depsipeptide, exerted activity in a mouse model of myelofibrosis (MF). New preclinical experiments reported herein found that low nanomolar plitidepsin concentrations potently inhibited the proliferation of JAK2V617F-mutated cell lines and reduced...

Full description

Saved in:
Bibliographic Details
Published in:Blood Cancer J
Main Authors: Pardanani, A, Tefferi, A, Guglielmelli, P, Bogani, C, Bartalucci, N, Rodríguez, J, Extremera, S, Pérez, I, Alfaro, V, Vannucchi, A M
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4382667/
https://ncbi.nlm.nih.gov/pubmed/25768401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2015.5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items